Swipe om te navigeren naar een ander artikel
Smoking worsens quality of life among HIV-infected individuals, but it remains unclear if this association is related simply to smoking or to chronic obstructive pulmonary disease (COPD), the end-organ disease caused by smoking.
Using cross-sectional data from the AIDS Linked to the Intravenous Experience study, we determined the independent effects of smoking, HIV and COPD assessed using the Medical Outcome Studies-HIV questionnaire.
Of 973 participants, 287 (29.5%) were HIV infected and 151 (15.5%) had spirometry-defined obstruction. Eight hundred and thirty-four (85.7%) were current smokers with 23.3 mean pack-years history. HIV infection was independently associated with reduced physical and mental health. COPD was associated with a trend toward worse physical health (−1.48 units; 95%CI −3.33 to 0.38; p = 0.12) and was independently associated with worse mental health (−2.43 units; 95%CI −4.22 to −0.64; p < 0.01). After accounting for COPD and other covariates, smoking was not associated with changes in physical or mental health.
The presence of COPD, rather than smoking, is associated with worse quality of life independent of HIV infection. Diagnosis and management of COPD in former or current smokers with or at risk for HIV may further improve quality of life.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Hays, R. D., Cunningham, W. E., Sherbourne, C. D., Wilson, I. B., Wu, A. W., Cleary, P. D., et al. (2000). Health-related quality of life in patients with human immunodeficiency virus infection in the United States: Results from the HIV cost and services utilization study. American Journal of Medicine, 108, 714–722. CrossRefPubMed
Lucas, G. M., Mehta, S. H., Atta, M. G., Kirk, G. D., Galai, N., Vlahov, D., et al. (1988). End-stage renal disease, chronic kidney disease in a cohort of African-American HIV-infected, at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS, 2007(21), 2435–2443.
Simone, M. J., & Appelbaum, J. (2008). HIV in older adults. Geriatrics, 63, 6–12. PubMed
Carone, M., Bertolotti, G., Anchisi, F., Zotti, A. M., Donner, C. F., & Jones, P. W. (1999). Analysis of factors that characterize health impairment in patients with chronic respiratory failure. Quality of life in chronic respiratory failure group. European Respiratory Journal, 13, 1293–1300. CrossRefPubMed
Burns, D. N., Hillman, D., Neaton, J. D., Sherer, R., Mitchell, T., Capps, L., et al. (1996). Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry beirn community programs for clinical research on AIDS. Journal of Acquired Immune Deficiency Syndromes Human Retrovirology, 13, 374–383.
Diaz, P. T., Clanton, T. L., & Pacht, E. R. (1992). Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Annals of Internal Medicine, 116, 124–128. PubMed
Diaz, P. T., King, M. A., Pacht, E. R., Wewers, M. D., Gadek, J. E., Nagaraja, H. N., et al. (2000). Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Annals of Internal Medicine, 132, 369–372. PubMed
Vlahov, D., Anthony, J. C., Munoz, A., Margolick, J., Nelson, K. E., Celentano, D. D., et al. (1991). The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Research Monograph, 109, 75–100. PubMed
Revicki, D. A., Wu, A. W., & Murray, M. I. (1995). Change in clinical status, health status, and health utility outcomes in HIV-infected patients. Medical Care, 33, AS173–AS182. PubMed
Hankinson, J. L., Odencrantz, J. R., & Fedan, K. B. (1999). Spirometric reference values from a sample of the general U.S. population. American Journal of Respiratory Critical Care Medicine, 159, 179–187.
Ruiz Perez, I., Rodriguez Bano, J., Lopez Ruz, M. A., del Arco Jimenez, A., Causse Prados, M., Pasquau Liano, J., et al. (2005). Health-related quality of life of patients with HIV: Impact of sociodemographic, clinical and psychosocial factors. Quality of Life Research, 14, 1301–1310. CrossRefPubMed
Badia, X., Podzamczer, D., Casado, A., Lopez-Lavid, C., & Garcia, M. (2000). Evaluating changes in health status in HIV-infected patients: Medical outcomes study-HIV and multidimensional quality of life-HIV quality of life questionnaires. Spanish MOS-HIV and MQOL-HIV validation group. AIDS, 14, 1439–1447. CrossRefPubMed
Wu, A. W., Jacobson, D., Grant, D., Scott-Lennox, J. (1997). Quality of life scores predict clinical trial attrition and mortality. Abstracts of 4th Conf on Retroviruses Opportun Infect, 31, 298.
Shahriar, J., Delate, T., Hays, R. D., Coons, S. J. (2003). Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease. Health Qual Life Outcomes, 1, 25.
Oramasionwu, C. U., Brown, C. M., Ryan, L., Lawson, K. A., Hunter, J. M., & Frei, C. R. (2009). HIV/AIDS disparities: the mounting epidemic plaguing US blacks. Journal of the National Medical Association, 101, 1196–1204. PubMed
Des Jarlais, D. C., & Friedman, S. R. (1987). HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS, 1, 67–76. PubMed
- HIV and COPD: impact of risk behaviors and diseases on quality of life
M. Bradley Drummond
Gregory D. Kirk
Meredith C. McCormack
Mariah M. Marshall
Erin P. Ricketts
Shruti H. Mehta
Robert A. Wise
Christian A. Merlo
- Springer Netherlands